Monitoring the efficacy of chemotherapeutic drugs using dark field imaging

Somaiyeh Khoubafarin; Ashish Kharel; Saloni Malla; Peuli Nath; Devinder Kaur; Amit K. Tiwari; Aniruddha Ray

doi:10.1117/12.2609874

2 March 2022 Monitoring the efficacy of chemotherapeutic drugs using dark field imaging

Somaiyeh Khoubafarin, Ashish Kharel, Saloni Malla, Peuli Nath, Devinder Kaur, Amit K. Tiwari, Aniruddha Ray

Proceedings Volume 11972, Label-free Biomedical Imaging and Sensing (LBIS) 2022; 1197205 (2022) https://doi.org/10.1117/12.2609874
Event: SPIE BiOS, 2022, San Francisco, California, United States

Abstract

Chemotherapy is one of the most common anti-cancer treatments, that targets rapidly dividing cells by inducing DNA damage and inhibition of mitosis. Most chemotherapeutic drugs are known to induce apoptosis, which is programmed cell death. Therefore, monitoring cell death mechanism, in addition to its viability, is important for understanding the efficacy of treatment, and is particularly important during drug screening. Here we present an automated label-free method of testing the efficacy of chemotherapeutic drugs by identification of apoptotic cell death, based on the scattering signature of cancer cells, using dark field microscopy. Breast cancer cells (BT-20) were treated with different chemo-drugs and simultaneously imaged during the drug incubation step. A neural network was trained to identify the cells that remain alive, as well as distinguish between the cells undergoing apoptosis and necrosis, the two most common cell death mechanisms. The network identifies the cell death mechanism, based on the temporal changes in morphological properties of the cells, e.g. volume shrinkage, blebbing, membrane damage etc. Our results show that the network trained using a specific chemo-drug can then be used for identifying the cell death processes induced by other types of chemo-drugs, with over <95% accuracy, confirmed using western blot assay. This automated technique which can predict the cell death mechanism and viability in real time, during drug incubation, eliminates the additional steps, such as staining or adding conjugates, required for fluorescence imaging and western blot respectively, thereby making it user friendly, cost-effective and high throughput.

Conference Presentation

Citation Download Citation

Somaiyeh Khoubafarin, Ashish Kharel, Saloni Malla, Peuli Nath, Devinder Kaur, Amit K. Tiwari, and Aniruddha Ray "Monitoring the efficacy of chemotherapeutic drugs using dark field imaging", Proc. SPIE 11972, Label-free Biomedical Imaging and Sensing (LBIS) 2022, 1197205 (2 March 2022); https://doi.org/10.1117/12.2609874

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available